Alterity Therapeutics Limited

ASX (AUD): Alterity Therapeutics Limited (ATH)

Last Price

0.004

Today's Change

0.00 (0.00%)

Day's Change

0.004 - 0.005

Trading Volume

22,649,117

Overview

Market Cap

21 Million

Shares Outstanding

5 Billion

Avg Volume

6,770,081

Avg Price (50 Days)

0.00

Avg Price (200 Days)

0.00

PE Ratio

-0.40

EPS

-0.01

Earnings Announcement

03-Feb-2025

Previous Close

0.00

Open

0.00

Day's Range

0.004 - 0.005

Year Range

0.002 - 0.008

Trading Volume

22,649,117

Price Change Highlight

1 Day Change

0.00%

5 Day Change

0.00%

1 Month Change

33.33%

3 Month Change

33.33%

6 Month Change

-20.00%

Ytd Change

-42.86%

1 Year Change

0.00%

3 Year Change

-81.82%

5 Year Change

-83.67%

10 Year Change

-97.71%

Max Change

-99.20%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment